Genesis Biopharma, Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Genesis Biopharma, Inc
CIK #0001425205
EDGAR Form CIK 2011 - 2025
10-K [0001425205]
10-Q [0001425205]
3 [0001425205]
4 [0001425205]
5 [0001425205]
8-K [0001425205]
D [0001425205]
SC 13D [0001425205]
SC 13G [0001425205]
Form 13D/13G Filer Form 13D/13G Subject Filed
Perceptive Advisors LLC Iovance Biotherapeutics Inc [2024-03-01]
Point72 Asset Management LP Iovance Biotherapeutics Inc [2023-02-17]
BlackRock Inc Iovance Biotherapeutics Inc [2023-02-03]
State Street Corp Iovance Biotherapeutics Inc [2023-02-02]
MHR Fund Management LLC Iovance Biotherapeutics Inc [2022-12-30]
Wellington Management Group LLP Iovance Biotherapeutics Inc [2022-02-04]
ARK Investment Management LLC Iovance Biotherapeutics Inc [2021-01-11]
Price T Rowe Associates Inc /MD/ Iovance Biotherapeutics Inc [2020-02-14]
Vanguard Group Inc Iovance Biotherapeutics Inc [2020-02-11]
Acuta Capital Partners LLC Iovance Biotherapeutics Inc [2019-02-14]
View All
Form 3/4/5 Subject 2011 - 2025
Iovance Biotherapeutics Inc
Roche Corleen M.
Rosinack Matthew W.
Weiser Michael
Dukes Iain D.
Yarno Wendy L
Countouriotis Athena
Maynard Ryan D
Kirby Daniel Gordon
Bellemin Jean-Marc
Puri Raj K.
Vogt Frederick G
Graf Finckenstein Friedrich
Bilinsky IGOR
Rothbaum Wayne P.
McPeak Merrill A
Dixon Wendy L
Swartzburg Michael
Fardis Maria
Morris Timothy E
Hillsberg Sanford
Venkatesan Jay
Valle Franco
Schiffman Gregory T
Henderson Molly
Fischkoff Steven A.
Lotze Michael
Hawkins ELMA
Bender James G.
ACM Capital Partners, LLC
Ayer Capital Management, LP
Ayer Capital Partners, LLC
Radvanyi Laszlo
Handelman Michael D
Bristol Investment Fund Ltd
Bristol Capital LLC
Singh Manish
Voyticky David J
Kessler Paul L
Terms | Privacy | Guide
tony@aum13f.com